Clorox (CLX) Dips as Q2 Earnings Lag Estimates, Lowers View

Published on February 4, 2022

Clorox (CLX) Q2 results hurt by soft sales performance across all segments, led by lower shipment volumes. Higher costs also hurt the bottom line.

Continue reading on website
Other news

3 Oversold Growth Stocks That are Screaming Buys: ICU Medical, KBR, and AMN Healthcare Services

February 4, 2022
Rising concerns over mounting inflationary pressure and the Fed’s signal that it will raise interest rates several times this year are expected to fuel market turbulence in the near term....

LPL Financial (LPLA) Q4 Earnings Beat, Revenues & Costs Rise

February 4, 2022
LPL Financial (LPLA) records a year-over-year rise in revenues in the fourth quarter of 2021. However, higher expenses hurt results to some extent.